2 results  1 of 1 

1 Factors Influencing Skin Tolerability to the Rivastigmine Patch in Patients with Alzheimer's Disease
Hae Ri Na, Moon Ho Park, SangYun Kim, Dong Won Yang, Seong-Hye Choi, Hyun Duk Yang, YoungSoon Yang, Hyun Jeong Han, Jung Seok Lee, Young-Chul Yoon, Seong-Ho Koh, Jung Eun Kim, Bon D. Ku, Hee-Jin Kim, Kyung Won Park, Eun-Joo Kim, Bora Yoon, Key Jung Park
Dement Neurocogn Disord.2015;14(1):31-38.   Published online 2015 March 31     DOI: http://dx.doi.org/10.12779/dnd.2015.14.1.31
      
2 Efficacy and Safety of Switching from Oral Cholinesterase Inhibitors to the Rivastigmine Transdermal Patch in Patients with Probable Alzheimer's Disease
Hyun Jeong Han, Jeong Ju Lee, Sun A. Park, Hyun Young Park, Jeong Eun Kim, Young Soo Shim, Dong-Seok Shim, Eun-Joo Kim, Soo Jin Yoon, Seong Hye Choi
J Clin Neurol.2011;7(3):137-142.   Published online 2011 September 29     DOI: http://dx.doi.org/10.3988/jcn.2011.7.3.137
      

 1 of 1